NICE has today published a medical technologies guidance document recommending the use of gammaCore within the NHS for the acute and preventive treatment of cluster headache in the U.K. The guidance ...
A panel of 9 experts, including neurologists, other headache specialists, and medical and pharmacy directors, from 4 health plans (1 integrated delivery network and 3 plans with commercial, Medicare, ...
MIAMI (KFSN) -- Some patients say the pain is worse than childbirth! We're talking about cluster headaches. Now a little device may provide big relief to the more than 350,000 people in the US who are ...
ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper entitled ...
The FDA clearance was based on data from 2 studies. The Food and Drug Administration (FDA) has cleared gammaCore (electroCore), a non-invasive vagus nerve stimulator (nVNS) therapy, for adjunctive use ...
A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in ...
electroCore, a neuroscience and technology company dedicated to improving patient outcomes through technological advancement, announced today that the U.S. Food and Drug Administration (FDA) released ...
HOUSTON – Some patients say cluster headaches cause pain that’s worse than childbirth. Now, a little device may provide big relief to the more than 350,000 people in the U.S. who suffer from them.
PRESTO demonstrates clinical benefit of gammaCore in the acute treatment of migraine compared to sham BASKING RIDGE, N.J., Sept. 11, 2017 /PRNewswire/ -- electroCore, a neuroscience and technology ...
The device is applied to the neck and transmits a mild electrical stimulation to the vagus nerve through the skin. The Food and Drug Administration (FDA) has approved the use of gammaCore (electroCore ...
Cluster headache (CH) is an extremely painful primary headache disorder, which affects one to two people in every 1,000. [1] CH is known as being one of the worst pains known to man and is even more ...
The Food and Drug Administration approved a device on Tuesday meant to treat cluster headaches — a rare form of headache that affects mostly men. Subscribe to read this story ad-free Get unlimited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results